CIK 0001438133
- Large accelerated filer
TANDEM DIABETES CARE INC
Sign in to watch- Ticker
- TNDM
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 204327508
- Phone
- +1 858-366-6900
- Business address
- 12400 HIGH BLUFF DRIVE, San Diego, CA, 92130
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $32,555
- in 1 filing, $33K under 10b5-1 plans
Net −$32,555. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-15 | Novara Mark David EVP & CHIEF COMMERCIAL OFFICER | Exercise or conversion | +76 | 37,732 | ||
| 2026-05-15 | Novara Mark David EVP & CHIEF COMMERCIAL OFFICER | Shares withheld for taxes | −57 | $12.82 | $731 | 37,675 |
| 2026-05-15 | Novara Mark David EVP & CHIEF COMMERCIAL OFFICER | Exercise or conversion | +10,496 | 48,171 | ||
| 2026-05-15 | Novara Mark David EVP & CHIEF COMMERCIAL OFFICER | Shares withheld for taxes | −7,854 | $12.82 | $101K | 40,317 |
| 2026-05-15 | Novara Mark David EVP & CHIEF COMMERCIAL OFFICER | Exercise or conversion · Restricted Stock Unit | −76 | 304 | ||
| 2026-05-15 | Novara Mark David EVP & CHIEF COMMERCIAL OFFICER | Exercise or conversion · Restricted Stock Unit | −10,496 | 20,992 | ||
| 2026-03-17 | Novara Mark David EVP & CHIEF COMMERCIAL OFFICER | Sale | −187 | $23.05 | $4K | 37,656 |
| 2026-03-16 | Novara Mark David EVP & CHIEF COMMERCIAL OFFICER | Exercise or conversion | +7,414 | 43,383 | ||
| 2026-03-16 | Novara Mark David EVP & CHIEF COMMERCIAL OFFICER | Shares withheld for taxes | −5,540 | $21.59 | $120K | 37,843 |
| 2026-03-16 | Novara Mark David EVP & CHIEF COMMERCIAL OFFICER | Exercise or conversion · Restricted Stock Unit | −7,414 | 22,244 | ||
| 2026-03-05 | Novara Mark David EVP & CHIEF COMMERCIAL OFFICER | Sale 10b5-1 | −2 | $22.81 | $46 | 35,969 |
| 2026-02-17 | Novara Mark David EVP & CHIEF COMMERCIAL OFFICER | Exercise or conversion | +77 | 36,033 | ||
| 2026-02-17 | Novara Mark David EVP & CHIEF COMMERCIAL OFFICER | Shares withheld for taxes | −62 | $18.95 | $1K | 35,971 |
| 2026-02-17 | Novara Mark David EVP & CHIEF COMMERCIAL OFFICER | Exercise or conversion · Restricted Stock Unit | −77 | 380 | ||
| 2025-12-15 | Novara Mark David EVP & CHIEF COMMERCIAL OFFICER | Exercise or conversion | +7,415 | 39,799 | ||
| 2025-12-15 | Novara Mark David EVP & CHIEF COMMERCIAL OFFICER | Shares withheld for taxes | −3,843 | $22.11 | $85K | 35,956 |
| 2025-12-15 | Novara Mark David EVP & CHIEF COMMERCIAL OFFICER | Exercise or conversion · Restricted Stock Unit | −7,415 | 29,658 | ||
| 2025-11-17 | Novara Mark David EVP & CHIEF COMMERCIAL OFFICER | Exercise or conversion | +76 | 32,424 | ||
| 2025-11-17 | Novara Mark David EVP & CHIEF COMMERCIAL OFFICER | Shares withheld for taxes | −40 | $18.61 | $744 | 32,384 |
| 2025-11-17 | Novara Mark David EVP & CHIEF COMMERCIAL OFFICER | Exercise or conversion · Restricted Stock Unit | −76 | 457 |
Page 1 of 3 · 45 trades